Medicamentos Flashcards

1
Q

Inhibidores de la transcriptasa inversa nucleósidos (ITIN)

A

Abacavir, Lamivudina, Emtricitabina, Tenofovir, Zidovudina, Didanosina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ABC

A

Abacavir

*Precaución en carga viral > 100 000 y pacientes con alto riesgo CV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3TC

A

Lamivudina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

FTC

A

Emtricitabina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TDF

A

Tenofovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

AZT

A

Zidovudina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Combinaciones del grupo de los ITIN

A

TDF + FTC

ABC + 3TC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Inhibidores de la transcriptasa inversa no nucleósidos (ITINN)

A

Efavirenz

  • No se recomienda en embarazadas en I trimestre
  • *No se recomienda en uso de ACO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Inhibidores de integrasa (IINT)

A

Raltegravir, Dolutegravir, Elvitegravir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Inhibidores de proteasa (IP)

  • Menor eficacia
  • *Mayor intolerancia
A

Lopinavir + Ritonavir

Darunavir + Ritonavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

RAL

A

Raltegravir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DTG

A

Dolutegravir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

EVG

A

Elvitegravir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

LPV

A

Lopinavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

r

A

Ritonavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DVR

A

Darunavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Esquema preferente actual

A

2 ITIN + 1 IINT

18
Q

COBI

A

Cobicistat

19
Q

Boosters

A

Cobicistat

20
Q

Antagonistas de CCR5

A

Maraviroc

21
Q

ddI

A

Didanosina

*Solo cuando no se usan otros ITIN

22
Q

Esquema antiguo preferente

A

(AZT + 3TC) + EFV

(TDF + 3TC) + EFV

23
Q

Esquema antiguo alternativo

A

LPV/r + (ABC + 3TC)

LPV/r + (ddI + 3TC)

24
Q

Dosis de Efavirenz

A

600 mg HS

25
Q

Dosis de Zidovudina

A

300 mg c/12h

26
Q

Dosis de Lamivudina

A

150 mg c/12h

27
Q

Dosis de Tenofovir

A

300 mg c/24h

28
Q

Dosis de Abacavir

A

300 mg c/12h

29
Q

Dosis de Lopinavir

A

400 mg c/12h

30
Q

Dosis de Ritonavir

A

100 mg c/12h

31
Q

Esquema nuevo preferente

A

(3TC + ABC) + DTG

32
Q

Esquema nuevo alternativo

A

(3TC + ABC) + RAL

33
Q

MVC

A

Maraviroc

34
Q

Esquema preferente antiguo

A

2 ITIN + 1 ITINN

35
Q

Esquema preferente y alternativo actual

A

2 ITIN + 1 IINT

36
Q

Esquema alternativo antiguo

A

2 ITIN + 1 IP

37
Q

DRV

A

Darunavir

38
Q

Elección en Mujeres

A

(ABC+ 3TC) + DTG

(TDF + FTC) + EVG/cobi

39
Q

Elección en Embarazadas

A

(2 ITIN) + RAL o DVR/r

40
Q

Elección en > 65 años

A

(2 ITIN) + IINT

41
Q

Elección en Enfermedad avanzada

A

IINT o ITINN

  • IP como alternativa
  • No se recomienda ABC/3TC + Efavirenz en CV > 100 000 copias